Rabeprazole: Pharmacokinetics in patients with stable, compensated cirrhosis
- 30 April 1999
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 21 (4) , 691-701
- https://doi.org/10.1016/s0149-2918(00)88320-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer—a European multicentre studyAlimentary Pharmacology & Therapeutics, 1998
- RabeprazoleDrugs, 1998
- Current practice and future perspectives in the management of gastro-oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1997
- PantoprazoleDrugs, 1996
- Interaction of human liver cytochromes P450 in vitro with LY307640, a gastric proton pump inhibitorPharmacogenetics, 1996
- Clinical Pharmacokinetics of LansoprazoleClinical Pharmacokinetics, 1995
- Pharmacokinetics‐‐a relevant factor for the choice of a drug?Alimentary Pharmacology & Therapeutics, 1994
- Pharmacokinetics of [14C]Omeprazole in Patients with Liver CirrhosisClinical Pharmacokinetics, 1993
- Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazoleDigestive Diseases and Sciences, 1991
- Effect of Omeprazole on Nocturnal Intragastric pH in Cirrhotics with Inadequate Antisecretory Response to RanitidineDigestion, 1991